Hee-Cheol Kim | Physiology | Best Researcher Award-duplicate-1

Posted on by sciencefather

Prof. Dr. Hee-Cheol Kim | Neuroscience | Best Researcher Award

Professor at Keimyung University School of Medicine, South Korea.

Dr. Hee-Cheol Kim is a seasoned psychiatrist and researcher with over three decades of academic, clinical, and administrative experience. His extensive body of work focuses on neurodegenerative diseases, mental health, type 2 diabetes, and the application of electroconvulsive therapy (ECT). His contributions include numerous publications in reputable journals, a history of leadership roles, and impactful research collaborations.

Profile

Orcid

 

Education šŸŽ“:

Dr. Hee-Cheol Kim began his medical education at Keimyung University School of Medicine, earning his M.D. in 1988. He pursued advanced research in psychiatry, completing his Ph.D. in 2001 at Kyungpook National University. His postgraduate training included a rotating internship and residency in psychiatry at Keimyung University Dongsan Medical Center, solidifying his expertise in mental health care. Dr. Kim’s commitment to global learning led him to New York University School of Medicine, where he served as a visiting professor at the Aging and Dementia Research Center. His multidisciplinary academic foundation and international exposure underpin his innovative contributions to psychiatry and neuropsychiatric research.

Work Experience šŸ’¼:

Dr. Hee-Cheol Kimā€™s career spans academic, clinical, and administrative roles. Since 1996, he has been affiliated with Keimyung University School of Medicine, rising from lecturer to professor. He held prestigious positions, including Dean of the School of Medicine and Vice President of Keimyung University Dongsan Hospital. His administrative expertise extends to directing medical affairs and mental health centers in South Korea. Dr. Kim also led the Keimyung University Brain Research Institute, driving advancements in neuroscience. Internationally, he served as a visiting professor at NYU, where he contributed to dementia research. His leadership, combined with his dedication to patient care and teaching, has made him a pillar in the psychiatric community.

Awards and HonorsĀ šŸ†

Dr. Hee-Cheol Kim has received numerous accolades for his contributions to psychiatry and medical education. His groundbreaking research in dementia, mental health, and neurodegenerative diseases has earned him recognition within the academic and medical communities. Dr. Kim has been honored by prestigious organizations, including the Korean Neuropsychiatric Association and the Korean Society for Affective Disorders. His leadership in psychiatry education has also been acknowledged through awards for his excellence in teaching and mentorship. As a member of multiple national and international psychiatric organizations, he has been celebrated for his dedication to advancing mental health care and fostering interdisciplinary collaborations in research and clinical practice.

Research Interests:

Dr. Hee-Cheol Kimā€™s research is centered on neuropsychiatry, focusing on dementia, neurodegenerative diseases, and the intersection of mental health with chronic medical conditions like type 2 diabetes. He is a pioneer in using electroconvulsive therapy (ECT) for treatment-resistant psychiatric disorders and neurodevelopmental challenges. His studies explore how conditions such as depression and Alzheimerā€™s influence comorbidities, providing critical insights into geriatric mental health. During his tenure at NYU, he contributed to dementia research, emphasizing early diagnosis and interventions. Dr. Kimā€™s recent work includes investigating the impact of COVID-19 on mental health and the association between chronic diseases and neurodegeneration. His research bridges clinical practice and academia, offering innovative solutions to improve patient outcomes and enhance mental health care.

šŸ“š PublicationsĀ 

  • “Risk of dementia in patients with ageā€related medical conditions: a retrospective cohort study”
    • Authors: Not specified in accessible sources.
    • Published in: Psychogeriatrics
    • Year: 2024
    • DOI: 10.1111/psyg.13222
  • “Impact of COVID-19 on the development of major mental disorders in patients visiting a university hospital: a retrospective observational study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Yeungnam Medical Science
    • Year: 2024
    • DOI: 10.12701/jyms.2023.01256
  • “Effectiveness and Tolerability of Combination Pharmacotherapy With Stimulant and Non-Stimulant in Children With Attention Deficit Hyperactivity Disorder”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of the Korean Academy of Child and Adolescent Psychiatry
    • Year: 2024
    • DOI: 10.5765/jkacap.230048
  • “Risk of Neurodegenerative Diseases in Elderly Koreans with an Initial Diagnosis of Type 2 Diabetes: A Nationwide Retrospective Cohort Study”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Diabetes Research
    • Year: 2023
    • DOI: 10.1155/2023/7887792
  • “The Association Between Cancer and Neurodegenerative Diseases: A Retrospective Cohort Study Using the National Health Insurance Service-National Health Information Database”
    • Authors: Not specified in accessible sources.
    • Published in: Journal of Korean Neuropsychiatric Association
    • Year: 2021
    • DOI: 10.4306/jknpa.2021.60.4.307

ConclusionĀ 

Dr. Hee-Cheol Kim stands out as a compelling candidate for the Best Researcher Award due to his prolific academic record, innovative contributions to psychiatry, and significant influence on mental health practices in Korea and beyond. His career demonstrates a harmonious blend of research, teaching, and leadership, making him an exemplary figure in the field. Strengthening interdisciplinary collaborations and expanding his international footprint would further cement his legacy as a leading researcher.

 

Niki Vassilaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Niki Vassilaki | Neuroscience | Best Researcher Award Ā šŸ†

Researcher at Hellenic Pasteur Institute, Greece

Dr. Niki Vassilaki is a leading expert in Molecular Virology, specializing in the replication of Hepatitis C Virus (HCV) and viral infections such as those caused by Flaviviridae and SARS-CoV-2. She holds a PhD in Molecular Virology from the National and Kapodistrian University of Athens (NKUA) and completed postdoctoral research at Heidelberg University with Professor Ralf Bartenschlager. Dr. Vassilakiā€™s research focuses on the role of dopamine metabolism in viral infections and the development of antiviral drugs. With over 60 publications and more than 110 conference presentations, she has secured over ā‚¬1 million in competitive funding and is a key partner in the European EXPAND-EV program.

Profile

Scopus

Google Scholar

ORCID

Education šŸŽ“:

Dr. Niki Vassilaki completed her PhD in Molecular Virology at the Biology Department of the National and Kapodistrian University of Athens (NKUA), where she focused on Hepatitis C Virus (HCV) replication. Her doctoral research laid the foundation for her deep expertise in viral pathogenesis. She further expanded her knowledge and research capabilities during her postdoctoral studies at Heidelberg University, working in the world-renowned virology laboratory of Professor Ralf Bartenschlager. This experience allowed her to contribute to the development of robust infectious models for studying HCV replication, solidifying her reputation in the virology research community.

Work Experience šŸ’¼:

Dr. Niki Vassilaki has extensive experience in molecular virology, focusing on viral replication and pathogenesis. She pursued her PhD at the National and Kapodistrian University of Athens (NKUA) under the mentorship of Professor Mavromara, where she specialized in Hepatitis C Virus (HCV) replication. Following this, Dr. Vassilaki conducted postdoctoral research at Heidelberg University with Professor Ralf Bartenschlager, contributing to the development of a robust infectious model for HCV. Her current research explores the role of dopamine biosynthesis and metabolism in viral infections, particularly Flaviviridae and SARS-CoV-2, with an emphasis on antiviral drug discovery. She has also held leadership roles, including coordinator of multiple international research programs and membership in various virology and molecular biology committees.

Skills šŸ”

Dr. Niki Vassilaki possesses a broad range of skills in molecular virology, viral pathogenesis, and antiviral drug discovery. She has expertise in the molecular biology of Flaviviridae, Hepadnavirus (HBV), and SARS-CoV-2, with a strong focus on viral replication mechanisms and the identification of novel therapeutic targets. Dr. Vassilaki is skilled in advanced laboratory techniques, including PCR, RNA sequencing, and virus culture systems, as well as in designing and executing antiviral assays. Additionally, she has extensive experience in securing competitive funding, managing international research collaborations, and leading research teams focused on innovative antiviral solutions.

Research Interests:

Dr. Niki Vassilakiā€™s research interests lie at the intersection of molecular virology, viral pathogenesis, and antiviral drug discovery. Her work primarily focuses on the replication mechanisms of Flaviviridae viruses, Hepatitis B virus (HBV), and SARS-CoV-2. She is particularly interested in understanding the molecular interactions that govern viral replication and the development of novel replication inhibitors. Additionally, her research explores the role of dopamine biosynthesis and metabolism in viral infections, aiming to uncover how these pathways influence viral pathogenesis. Dr. Vassilaki is also dedicated to the discovery of antiviral agents, with her team developing an ISO-certified pipeline for screening and testing potential therapeutics.

šŸ“š PublicationsĀ 

  • Title: Alternate translation occurs within the core coding region of the hepatitis C viral genome
    • Authors: A Varaklioti, N Vassilaki, U Georgopoulou, P Mavromara
    • Journal: Journal of Biological Chemistry
    • Volume: 277, Issue 20, Pages: 17713-17721
    • Cited by: 238
    • Year: 2002
  • Title: Role of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and Replication
    • Authors: N Vassilaki, P Friebe, P Meuleman, S Kallis, A Kaul, G Paranhos-Baccala, …
    • Journal: Journal of Virology
    • Volume: 82, Issue 23, Pages: 11503-11515
    • Cited by: 130
    • Year: 2008
  • Title: Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core+1 coding open reading frame
    • Authors: N Vassilaki, P Mavromara
    • Journal: Journal of Biological Chemistry
    • Volume: 278, Issue 42, Pages: 40503-40513
    • Cited by: 122
    • Year: 2003
  • Title: The HCV ARFP/F/core+1 protein: production and functional analysis of an unconventional viral product
    • Authors: N Vassilaki, P Mavromara
    • Journal: IUBMB Life
    • Volume: 61, Issue 7, Pages: 739-752
    • Cited by: 91
    • Year: 2009
  • Title: Low oxygen tension enhances hepatitis C virus replication
    • Authors: N Vassilaki, KI Kalliampakou, I Kotta-Loizou, C Befani, P Liakos, G Simos, …
    • Journal: Journal of Virology
    • Volume: 87, Issue 5, Pages: 2935-2948
    • Cited by: 65
    • Year: 2013
  • Title: Impact of age and sex on antibody response following the second dose of COVID-19 BNT162b2 mRNA vaccine in Greek healthcare workers
    • Authors: N Vassilaki, AN Gargalionis, A Bletsa, N Papamichalopoulos, E Kontou, …
    • Journal: Microorganisms
    • Volume: 9, Issue 8, Article: 1725
    • Cited by: 60*
    • Year: 2021

ConclusionĀ 

Dr. Niki Vassilaki’s academic credentials, groundbreaking research, leadership in international committees, and professional affiliations make her a highly deserving candidate for the Research for Best Researcher Award. Her contributions to molecular virology, antiviral discovery, and global scientific collaborations highlight her excellence and dedication to advancing the field.

Yuandong Gu | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Yuandong Gu | Neuroscience | Best Researcher AwardĀ  Ā šŸ†

Vice President at National Innovation Center par Excellence, China

Prof. Dr. Yuandong Gu is a distinguished researcher and innovator in microelectronics and sensor technology. He serves as the Vice Dean of the Shanghai Yangtze Delta Innovation Institute and was the Founding Dean of the School of Microelectronics at Shanghai University. With a PhD from the University of Minnesota, Twin Cities (2003), his research focuses on piezoelectric MEMS sensors, photonic metamaterials, and their transformative applications. Prof. Gu has held key leadership roles, including Deputy Executive Director at Singaporeā€™s Institute of Microelectronics and Principal Scientist at Honeywell International Inc. He is the author of over 180 peer-reviewed publications and holds 55 USA/SGP patents. His groundbreaking work has earned him prestigious accolades, such as the Shanghai Talent Program Award (2018) and the Engineering Achievement Award from the Institution of Engineers Singapore.

Profile

Scopus

Education šŸŽ“:

Prof. Dr. Yuandong Gu earned his PhD in 2003 from the University of Minnesota, Twin Cities, specializing in advanced sensor technologies and microelectronics. His doctoral work laid the foundation for his illustrious career in piezoelectric MEMS sensors and photonic metamaterials, fields where he has made groundbreaking contributions. His strong academic background is complemented by his ability to bridge theoretical research with industrial applications, making him a leader in innovative technology development.

Work Experience šŸ’¼:

Prof. Dr. Yuandong Gu has extensive experience in academia, research, and industry, serving as the Vice President of the Shanghai Yangtze Delta Innovation Institute and Chairman of Shanghai Melon Technology Co., Ltd. He was the Founding Dean of the School of Microelectronics at Shanghai University and a Senior Vice President at SITRI, driving technology commercialization and innovation strategies. At A-STAR Singapore, he led advanced MEMS research as Deputy Executive Director, and at Honeywell International, he managed multi-million-dollar MEMS projects and established the Shanghai Sensors Lab, showcasing his global leadership in microelectronics and sensor technologies.

Skills šŸ”

Prof. Dr. Yuandong Gu is a highly skilled researcher and leader with expertise in microelectronics, piezoelectric MEMS technologies, and photonic metamaterials. He excels in strategic planning, technology incubation, and the development of cutting-edge sensor platforms, including pMUTs and MEMS-based force sensing modules. His proficiency in project management, cross-functional team leadership, and research-to-market transformation has been demonstrated through his successful execution of multimillion-dollar projects and the commercialization of innovative technologies. With a strong foundation in intellectual property generation, holding 55 patents, and an extensive publication record, he combines technical expertise with visionary leadership to drive impactful advancements in the field.

Research Interests:

Prof. Dr. Yuandong Guā€™s research interests encompass cutting-edge advancements in piezoelectric MEMS sensors, photonic metamaterials, and their diverse applications. His work focuses on developing innovative sensing technologies, such as piezoelectric micromachined ultrasonic transducers (pMUTs), and exploring the integration of photonic metamaterials to enhance device performance in various fields. These research efforts aim to address challenges in miniaturization, high precision, and energy efficiency, contributing to advancements in areas such as healthcare, robotics, and communication systems. His dedication to translating research into impactful technologies underscores his contributions to the global microelectronics and sensors community.

šŸ“š PublicationsĀ 

A 16-channel Si Probe Monolithically Integrated with CMOS Chips for Neural Recording

  • Authors: Gou, G.-Y., You, C., Yao, P., Xue, N., Zhao, M.
  • Journal: Sensors and Actuators Reports
  • Publication Year: 2024
  • Volume: 8
  • Article Number: 100206
  • Open Access

Improved Performance of Acoustically Actuated Magnetoelectric Antenna with FeGa/FeGaB Bilayer

  • Authors: Li, K., Zhang, Q., Chang, Y., Zhang, S., Gu, Y.
  • Journal: Micromachines
  • Publication Year: 2024
  • Volume: 15
  • Issue: 2
  • Article Number: 190
  • Open Access

Effect of Humid Environment on Electromechanical Performance of Piezoelectric Micromachined Ultrasonic Transducers (PMUTs)

  • Authors: Tong, Z., Wu, Z., Gu, Y.A., Lou, L.
  • Journal: Sensors and Actuators A: Physical
  • Publication Year: 2024
  • Volume: 366
  • Article Number: 114821

MHorUNet: High-Order Spatial Interaction UNet for Skin Lesion Segmentation

  • Authors: Wu, R., Liang, P., Huang, X., Zhu, H., Chang, Q.
  • Journal: Biomedical Signal Processing and Control
  • Publication Year: 2024
  • Volume: 88
  • Article Number: 105517
  • Citations: 13

Enhancement in Performance of SAW Resonator on LN/SiC Substrate by Taking Slowness Asymmetry into Account

  • Authors: Liu, H.L., Zhang, Q.Z., Sun, H., Gu, Y.D., Wang, N.
  • Journal: Journal of Physics: Conference Series
  • Publication Year: 2024
  • Volume: 2822
  • Issue: 1
  • Article Number: 012174

A Miniaturized Transit-Time Ultrasonic Flowmeter Based on ScAlN Piezoelectric Micromachined Ultrasonic Transducers for Small-Diameter Applications

  • Authors: Gao, Y., Chen, M., Wu, Z., Gu, Y.A., Lou, L.
  • Journal: Microsystems and Nanoengineering
  • Publication Year: 2023
  • Volume: 9
  • Issue: 1
  • Article Number: 49
  • Citations: 15

A Highly Integrated 3D MEMS Force Sensing Module With Variable Sensitivity for Robotic-Assisted Minimally Invasive Surgery

  • Authors: Hou, C., Wang, K., Wang, F., Chen, T., Sun, L.
  • Journal: Advanced Functional Materials
  • Publication Year: 2023
  • Volume: 33
  • Issue: 43
  • Article Number: 2302812
  • Citations: 12

ConclusionĀ 

Prof. Dr. Yuandong Gu’s extensive contributions to advanced sensor technology, impactful industrial innovations, and dedication to academic mentorship make him a strong candidate for the Research for Best Researcher Award. His balance of academic rigor, innovation, and leadership perfectly aligns with the award’s criteria, reflecting his global stature as a transformative researcher.

 

Ioannis Charalampopoulos | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof. Ioannis Charalampopoulos
| Neuroscience | Best Researcher Award šŸ†

Professor of Pharmacology at Medical School, University of Crete,GreecešŸŽ“

Dr. Ioannis Charalampopoulos is a distinguished Professor of Pharmacology at the University of Crete’s Medical School and a Group Leader at the Institute of Molecular Biology and Biotechnology (IMBB), Foundation of Research and Technology, Hellas (FORTH). With a focus on neuropharmacology and molecular biology, his research has contributed significantly to the study of neurodegenerative diseases, brain development, and regeneration. He has an extensive academic and research career spanning over two decades, with notable achievements in the development of novel therapeutic strategies for Alzheimerā€™s and spinal cord injury.

 

Professional ProfileĀ 

Education šŸŽ“:

  • 2021-present: Director of the Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, Medical School, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden
  • 2001-2005: PhD in Pharmacology, Medical School, University of Crete
  • 1998-2000: Master of Science in Neurosciences, Medical School, University of Crete
  • 1990-1996: BSc, Department of Biology, University of Patras

Work Experience šŸ’¼:

  • 2023-present: Professor of Pharmacology, Medical School, University of Crete
  • 2018-present: Researcher/Group Leader, Institute of Molecular Biology and Biotechnology (IMBB), FORTH
  • 2021-present: Director, Graduate Program in Neurosciences, Medical School, University of Crete
  • 2010-2023: Lecturer, Assistant and Associate Professor of Pharmacology, University of Crete
  • 2007-2010: Researcher, Medical School, University of Crete
  • 2005-2007: Post-doctoral Fellow, Molecular Neurobiology Lab, Karolinska Institutet, Sweden

Skills šŸ”

Dr. Charalampopoulos is highly skilled in neuropharmacology, molecular biology techniques, and neurodegenerative disease research. His expertise includes:

  • Neurotrophin receptor structure-function analysis
  • Development of therapeutic ligands for brain regeneration
  • Neurogenesis and neuroprotection strategies
  • Animal models of Alzheimerā€™s disease and spinal cord injury
  • Human iPSC-derived neural platforms for disease modeling
  • Collaborative research in neuroscience and pharmacology

Awards and Honors šŸ†

Dr. Charalampopoulos has received multiple recognitions throughout his career, including prestigious grants for his innovative work in neuroscience and neurodegenerative disease treatment:

  • HORIZON-EIC-2022 European Commission Grant: Coordinating a project on soft-robot-assisted therapeutic delivery for neurological disorders (budget: 2.9 million euros).
  • National Flagship Project: Funding for the elucidation of the genetic basis of Alzheimer’s and Parkinson’s diseases (budget: 610,000 euros).
  • Numerous research accolades, with over 80 publications in peer-reviewed journals (h-index: 35, citations >3000).

šŸ¤ Memberships:

Dr. Charalampopoulos is a member of several prestigious scientific organizations, including:

  • International Society for Neuroscience
  • European Society of Neurochemistry
  • Society for Neuroscience (SfN)
  • Greek Society for Pharmacology

Teaching Experience šŸ‘©ā€šŸ«:

Dr. Charalampopoulos has been actively involved in educating future generations of neuroscientists, particularly through his role as the Director of the Graduate Program in Neurosciences at the University of Crete. His teaching experience includes:

  • Undergraduate and postgraduate courses in pharmacology, neuropharmacology, and molecular biology.
  • Mentoring and supervising PhD students and postdoctoral researchers in pharmacology and neuroscience.
  • Developing innovative teaching methods, including the use of human stem cell models in neuroscience research.

Research Focus šŸ”¬:

Dr. Charalampopoulos’ research interests revolve around the molecular mechanisms by which growth factors and their receptors regulate the regenerative capacity of the nervous system. Key areas include:

  • Neurotrophins: Their role in brain development, neurogenesis, neuronal survival, and repair during aging.
  • Neurodegenerative Diseases: Investigating novel therapeutic strategies for Alzheimer’s disease, Parkinsonā€™s disease, and spinal cord injury.
  • Ligand Development: Creating novel ligands targeting neurotrophin receptors to enhance regenerative and neuroprotective effects.
  • Stem Cell Models: Using human induced pluripotent stem cell-derived platforms to test therapeutics for neurodegenerative diseases.
    His ultimate goal is to decipher the signaling mechanisms underlying neurodegeneration and regeneration, leading to the development of novel drugs for brain repair.
ConclusionĀ 

Dr. Ioannis Charalampopoulos is undoubtedly a top contender for the Best Researcher Award. His exceptional contributions to neuroscience, his innovative approaches in neuropharmacology, and his ability to secure substantial research funding demonstrate that he is not only an accomplished researcher but also a transformative figure in the field of neurodegenerative diseases. His strengths lie in the originality of his work, leadership in research initiatives, and mentorship in education. With slight improvements in public outreach, collaborative networks, and clinical translation, he can further elevate his already remarkable career. Therefore, Dr. Charalampopoulos is a highly deserving nominee for the Best Researcher Award, given his outstanding scientific contributions, leadership, and lasting impact on the field of neuroscience.

šŸ“š Publilcation

  • “Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease”
    • Year: 2024
    • Journal: Frontiers in Cellular Neuroscience
    • Type: Review
    • DOI: 10.3389/fncel.2024.1422130
  • “Editorial: Steroid receptors in neuron and glia”
    • Year: 2024
    • Journal: Frontiers in Endocrinology
    • Type: Editorial
    • DOI: 10.3389/fendo.2024.1472908
  • “Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimerā€™s disease”
    • Year: 2024
    • Journal: Stem Cell Research & Therapy
    • Type: Journal Article
    • DOI: 10.1186/s13287-024-03818-w
  • “Cover Image, Volume 72, Issue 4”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24399
  • “Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer’s disease and the protective role of BDNF”
    • Year: 2024
    • Journal: Glia
    • Type: Journal Article
    • DOI: 10.1002/glia.24505
  • “Multimodal beneficial effects of BNN27, a Nerve Growth Factor synthetic mimetic, in the 5xFAD mouse model of Alzheimerā€™s Disease”
    • Year: 2024
    • Type: Preprint
    • DOI: 10.21203/rs.3.rs-3886007/v1
  • “Development of Pleiotropic TrkB and 5-HT<sub>4</sub> Receptor Ligands as Neuroprotective Agents”
    • Year: 2024
    • Journal: Molecules
    • Type: Journal Article
    • DOI: 10.3390/molecules29020515
  • “Butanolides and Butenolides from a Marine-Derived Streptomyces sp. Exert Neuroprotective Activity through Activation of the TrkB Neurotrophin Receptor”
    • Year: 2023
    • Journal: Marine Drugs
    • Type: Journal Article
    • DOI: 10.3390/md21090465
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor, Regulating Neuronal Survival in a Cell Context-Dependent Manner”
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Type: Journal Article
    • DOI: 10.3390/ijms241411683
  • “Neurotrophin Analog ENT-A044 Activates the p75 Neurotrophin Receptor Promoting Cell Death in Mouse and Human Neuronal Cells”
    • Year: 2023
    • Type: Preprint
    • DOI: 10.20944/preprints202306.1633.v1

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Posted on by sciencefather

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award šŸ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,Ā Japan
šŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional ProfileĀ 

šŸ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

šŸŽ–ļø Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

šŸŒ Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofengā€™s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :Ā 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences